MAKENZIE EVINGER: Open Payments
NPI 1619609989 · ODESSA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| UCB, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| PFIZER INC. | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| REVANCE THERAPEUTICS, INC. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
Products named: TREMFYA, ACTHAR, Bimzelx, PREVNAR 20, RINVOQ, Ohtuvayre, CAPVAXIVE, DAXXIFY.
Industry payments across MO — which companies pay providers there.
